Cargando…

Efficacy of post‑mastectomy radiotherapy in patients with T1‑2N1 breast cancer aged ≤35 years or with a positive HER‑2 status

Post-mastectomy radiotherapy (PMRT) is highly recommended for patients with breast cancer with one to three positive nodes; however, there remains some controversy regarding its use. The present retrospective study aimed to explore which patients may be able to avoid PMRT and its associated side eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mincong, Wang, Yali, Xie, Fei, Ren, Hongtao, Chen, Jing, Wang, Zhongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288432/ https://www.ncbi.nlm.nih.gov/pubmed/37359715 http://dx.doi.org/10.3892/mco.2023.2654

Ejemplares similares

21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer
por: Zhang, Wen-Wen, et al.
Publicado: (2019)

Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy
por: Sun, Guang-Yi, et al.
Publicado: (2021)

Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis
por: Li, Yaming, et al.
Publicado: (2013)

Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes
por: Wu, Sangang, et al.
Publicado: (2014)

Utility of post mastectomy radiotherapy among patients with T1/ T2 N1 disease: A retrospective cohort study
por: Vohra, Lubna M., et al.
Publicado: (2021)

The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis
por: Kim, Kangpyo, et al.
Publicado: (2023)

Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
por: Schwartz, Theresa L., et al.
Publicado: (2015)

Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression
por: Ren, Hongtao, et al.
Publicado: (2022)

Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
por: Wang, Qian, et al.
Publicado: (2020)

Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
por: Verma, Rashmi, et al.
Publicado: (2023)

Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1–2 tumor and 1–3 axillary lymph node(s) metastasis
por: Su, Yu-Li, et al.
Publicado: (2014)

T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy
por: Wang, Xueying, et al.
Publicado: (2020)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
por: Ishimine, Yu, et al.
Publicado: (2015)

Changes in the detection of human epidermal growth factor receptor 2 gene (Her-2) status for Her-2 fluorescent in situ hybridization testing
por: Xu, Ying, et al.
Publicado: (2022)

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy
por: Zhao, Xuran, et al.
Publicado: (2020)

Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases
por: Yang, Xiaojing, et al.
Publicado: (2023)

Influence of the Presence of Tissue Expanders on Energy Deposition for Post-Mastectomy Radiotherapy
por: Trombetta, Débora M., et al.
Publicado: (2013)

The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
por: Wang, Jun, et al.
Publicado: (2019)

Her2 Status Discrepancy Between Core Needle Biopsy and Surgically Resected Mastectomy Specimen: A Clinical Case
por: Vasques, Ana Carolina, et al.
Publicado: (2023)

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2021)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients
por: Dong, Zhouhuan, et al.
Publicado: (2019)

De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy
por: Liu, Jing, et al.
Publicado: (2023)

Post-mastectomy Radiotherapy in T1-2 Breast Cancer Patients With One to Three Lymph Node Metastases: A Propensity Score Matching Analysis
por: Chen, Maoshan, et al.
Publicado: (2020)

Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
por: Laidi, Fatna, et al.
Publicado: (2014)

Intratumor lactate levels reflect HER2 addiction status in HER2‐positive breast cancer
por: Castagnoli, Lorenzo, et al.
Publicado: (2018)

Skin-sparing mastectomy and radiotherapy: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Current status of and trends in post-mastectomy breast reconstruction in Korea
por: Song, Woo Jin, et al.
Publicado: (2020)

Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
por: Tseng, Michelle, et al.
Publicado: (2020)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2
por: Wang, Bo-Wei, et al.
Publicado: (2021)

Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients
por: Xie, Yibo, et al.
Publicado: (2020)

Effect of bladder filling status on positioning errors in post-hysterectomy cervical cancer radiotherapy
por: Ge, Bin-Bin, et al.
Publicado: (2023)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer
por: Zhang, Hang, et al.
Publicado: (2017)

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift
por: Ippolito, Edy, et al.
Publicado: (2022)

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
por: Wang, Shulian, et al.
Publicado: (2020)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
por: Ding, Yi, et al.
Publicado: (2018)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
por: Ma, Bo, et al.
Publicado: (2016)

Review of the status of neoadjuvant therapy in HER2-positive breast cancer
por: Dowling, Gavin P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0ccu4bh25frb3uahtc09vm5ik